RTOG 0813近端支气管树约束对中央型NSCLC SBRT肺毒性的验证
本研究基于1462例前瞻性登记库中132例距近端支气管树≤2 cm的中央型非小细胞肺癌患者,接受根治性立体定向体部放疗,系统分析近端支气管树剂量体积组合与肺毒性的关系。结果发现高剂量小体积约束(如D0.03cc≤5000 cGy)对非肺炎性毒性预测优于RTOG 0813约束,且未发现近端支气管树剂量与肺炎性毒性的相关性。
要点
- 高剂量小体积PBT约束对非肺炎性毒性预测优于RTOG 0813约束。
- D0.03cc≤5000 cGy预测2-5级NPT的敏感度87.5%、特异度76.6%。
- 未发现PBT剂量与肺炎性毒性存在相关性。
核心结论
- 本剂量学分析验证了现行RTOG近端支气管树约束,并强调高剂量小体积约束是非肺炎性毒性的更好预测指标。
- 稍低的近端支气管树最大点剂量约束可能更适合识别非肺炎性毒性。
研究设计与样本
- 从1462例前瞻性登记库中筛选2009至2016年接受根治性立体定向体部放疗、病灶距近端支气管树≤2 cm的中央型非小细胞肺癌患者。
- 共纳入132例患者,中位随访26.0个月。
- 分析近端支气管树从0 cGy至8000 cGy(步长10 cGy)与体积从0.03 cm3至50 cm3(步长0.03 cm3)的所有剂量体积组合,计算敏感度和特异度,以F-score选择最佳剂量学预测指标。
主要发现
- 观察到8例≥2级非肺炎性毒性(其中2例5级)和8例2级肺炎性毒性。
- 预测2至5级非肺炎性毒性F-score最高的近端支气管树剂量学终点为D0.03cc≤5000 cGy,敏感度87.5%、特异度76.6%。
- 预测3至5级非肺炎性毒性F-score最高的终点为D0.33cc≤4710 cGy,敏感度100.0%、特异度85.7%。
- 应用RTOG 0813近端支气管树约束于本数据集,D4cc≤1800 cGy识别2至5级非肺炎性毒性的敏感度33.3%、特异度92.1%。
- D0.03cc≤5250 cGy识别2至5级非肺炎性毒性的敏感度37.5%、特异度92.7%。
关键数值与推荐
- 预测2至5级非肺炎性毒性:D0.03cc≤5000 cGy(敏感度87.5%,特异度76.6%)。
- 预测3至5级非肺炎性毒性:D0.33cc≤4710 cGy(敏感度100.0%,特异度85.7%)。
- RTOG 0813约束D4cc≤1800 cGy识别2至5级非肺炎性毒性:敏感度33.3%,特异度92.1%。
- RTOG 0813约束D0.03cc≤5250 cGy识别2至5级非肺炎性毒性:敏感度37.5%,特异度92.7%。
临床怎么用
- 对中央型非小细胞肺癌行立体定向体部放疗时,可优先关注近端支气管树高剂量小体积约束(如D0.03cc≤5000 cGy)以预测非肺炎性毒性。
- RTOG 0813近端支气管树约束仍可作为一种保守约束参考,但其对非肺炎性毒性的敏感度较低。
- 近端支气管树剂量学参数不宜用于预测肺炎性毒性。
局限性
- 本研究为单机构回顾性分析,样本量有限(132例),事件数较少。
- 随访时间有限(中位26.0个月)。
- 作者指出需在更大样本、更长随访的队列中验证上述发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Clinical validation of protocol-specified dosimetric constraints for the proximal bronchial tree (PBT) is limited for central non-small cell lung cancer treated with stereotactic body radiation therapy. We sought to validate Radiation Therapy Oncology Group (RTOG) PBT constraints with a large institutional data set. METHODS AND MATERIALS: Lesions ≤2 cm from the PBT treated with definitive stereotactic body radiation therapy from 2009 to 2016 were identified from a prospective registry of 1462 patients. Every PBT dose and volume combination, ranging from 0 cGy to 8000 cGy in increments of 10 cGy and volumes ranging from 0.03 cm3 to 50 cm3 in increments of 0.03 cm3, was analyzed. The sensitivity and specificity of these endpoints for identifying pulmonary toxicity were calculated. Pulmonary toxicity was classified as pneumonitis or nonpneumonitis toxicity (NPT) (fistula, stenosis, necrosis, hemoptysis, clinically significant pleural effusion). The optimal dosimetric predictor was chosen by calculation of F-score (highest sensitivity and specificity). RESULTS: The study included 132 patients, with 26.0-month median follow-up. Eight grade ≥2 NPT (2 grade 5) and 8 grade 2 pneumonitis toxicities were observed. The PBT dosimetric endpoint with the highest F-score for identification of grade 2 to 5 NPT was D0.03cc ≤5000 cGy and that for grade 3 to 5 NPT was D0.33cc ≤4710 cGy, with sensitivity and specificity of 87.5% and 76.6% and 100.0% and 85.7%, respectively. Applying the RTOG 0813 PBT constraints to our data set achieved a sensitivity and specificity of 33.3% and 92.1% for D4cc ≤1800 cGy and 37.5% and 92.7% for D0.03cc ≤5250 cGy for identification of grade 2 to 5 NPT. A PBT dosimetric correlation for pneumonitis toxicity could not be identified. CONCLUSIONS: This novel dosimetric analysis validates current RTOG constraints and emphasizes high-dose, small-volume constraints as better predictors for NPT. We demonstrated that a slightly lower maximum point dose PBT constraint may be optimal for identification of NPT. Validation of these findings in a larger cohort of patients with longer follow-up is necessary.
引用
- Manyam BV, Verdecchia K, Videtic GMM, et al. Validation of RTOG 0813 Proximal Bronchial Tree Constraints for Pulmonary Toxicity With Stereotactic Body Radiation Therapy for Central Non-small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2020. PMID: 31987965. doi:10.1016/j.ijrobp.2020.01.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。